Psoriasis is a chronic inflammatory dermatosis of uncertain cause classified as a systemic disease based on recent research. It is prevalent in the global adult population at about 2%. This dermatosis often occurs simultaneously with metabolic syndrome, other serious disorders, and is associated with chronic inflammation, immune disorders, genetic factors, and a variety of biologically active substances secreted by adipose tissue (Fernández-Armenteros JM, J Eur Acad Dermatol Venereolo 33:128–135, 2019). Due to these factors, psoriasis patients are at higher risk of obesity, diabetes mellitus, hypertension, dyslipidemia, and atherosclerosis. Furthermore, these diseases increase the likelihood of cardiovascular events (Ryan C and Kirby B, Dermatol Clin 33:41–55, 2015). In addition, previous research indicates that patients suffer from insomnia and experience poor sleep quality (Mann C et al., J Dtsch Dermatol Ges 21:577–584, 2023). The comorbidities mentioned above directly increase the risk of sexual dysfunction (Cirillo L et al., Arch Ital Urol Androl 95:11236, 2023) in both men and women.